algaederiv
lectin
one
potent
viral
entri
inhibitor
discov
date
current
develop
microbicid
broadspectrum
activ
sever
envelop
virus
grft
inhibit
human
immunodefici
viru
hiv
infect
picomolar
concentr
surpass
abil
antihiv
agent
potenti
inhibit
virus
well
parasit
also
demonstr
griffithsin
antivir
activ
stem
abil
bind
termin
mannos
present
highmannos
oligosaccharid
crosslink
glycan
surfac
viral
envelop
glycoprotein
review
structur
biochem
studi
establish
mode
action
facilit
construct
grft
analog
mechan
may
lead
resist
vitro
preclin
result
support
therapeut
potenti
lectin
number
lifethreaten
human
diseas
caus
virus
divers
human
immunodefici
viru
hiv
ebola
yellow
fever
zika
influenza
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
corona
virus
sarscov
merscov
respect
though
virus
taxonom
genet
distinct
envelop
virus
therefor
possess
lipid
bilay
protect
viral
capsid
genet
materi
insid
viral
particl
despit
effort
erad
diseas
number
continu
affect
us
either
pandem
diseas
outbreak
appear
time
time
exampl
accord
world
health
organ
end
nearli
million
peopl
infect
hiv
two
million
new
case
one
million
death
occur
year
http
wwwwhoint
hand
nearli
case
death
report
recent
ebola
outbreak
start
sarscov
merscov
belong
corona
viru
famili
includ
common
cold
outbreak
virus
sarscov
asia
merscov
saudi
arabia
led
sever
thousand
case
sar
mer
hundr
death
effort
creat
vaccin
viral
diseas
success
case
yellow
fever
case
like
hiv
challeng
envelop
virus
surfac
glycoprotein
mediat
attach
fusion
target
cell
membran
protein
constitut
first
encount
host
expos
target
immun
system
attack
henc
virus
evolv
hide
featur
would
make
suscept
antibodi
neutral
strategi
includ
hide
fundament
structur
motif
oligomer
conform
occlus
rapid
mutat
rate
lead
high
sequenc
variabl
nonessenti
region
variabl
loop
extens
posttransl
glycosyl
vaccin
develop
envelop
virus
mostli
focus
target
envelop
glycoprotein
primarili
sole
target
neutral
antibodi
virus
includ
hepat
c
viru
hcv
hiv
thu
far
elud
vaccin
effort
mostli
due
high
variabl
among
strain
high
mutat
rate
within
given
viru
physic
mask
neutral
epitop
develop
vaccin
diseas
appear
outbreak
ebola
sarscov
also
challeng
lack
infect
patient
popul
necessari
test
efficaci
vaccin
therapeut
diseas
yellow
fever
prevent
vaccin
diseas
vaccin
develop
challeng
therapi
nevertheless
develop
hiv
arguabl
studi
viral
diseas
highlyact
antiretrovir
therapi
haart
consist
combin
small
molecul
antiretrovir
drug
progress
improv
live
patient
part
world
effect
extend
life
expect
antiretrovir
drug
target
differ
protein
enzym
essenti
viru
life
cycl
hand
antibodi
therapeut
emerg
power
altern
form
therapi
hiv
diseas
therapi
depend
isol
neutral
monoclon
antibodi
primarili
patient
sera
bind
specif
envelop
glycoprotein
viru
anoth
way
treat
viral
diseas
current
studi
use
protein
capabl
target
glycan
present
surfac
envelop
glycoprotein
name
lectin
lectin
sugarbind
protein
ubiquit
present
microorgan
plant
anim
particip
mani
import
cellular
process
includ
cellcel
interact
protein
fold
lectin
provid
protect
host
organ
lectin
develop
wide
probe
investig
cell
surfac
structur
function
also
found
applic
antivir
drug
deliveri
chemotherapeut
agent
number
lectin
capabl
bind
highmannos
glycan
commonli
found
surfac
envelop
glycoprotein
current
studi
use
microbicid
promis
antivir
lectin
includ
griffithsin
grft
cyanovirin
cvn
banana
lectin
banlec
use
mostli
suggest
antivir
microbicid
act
barrier
prevent
transmiss
hiv
incorpor
vagin
rectal
gel
cream
suppositori
system
bind
virus
prevent
viral
entri
fusion
target
cell
therebi
prevent
infect
review
summar
activ
biochem
biophys
structur
data
avail
grft
one
potent
antihiv
agent
report
date
griffithsin
discov
antihiv
lead
research
nation
cancer
institut
nci
grft
isol
marin
red
alga
griffithsia
sp
present
nci
natur
product
repositori
mass
spectroscop
nuclear
magnet
reson
nmr
data
indic
activ
compound
protein
rather
small
molecul
natur
product
sequenc
determin
combin
ntermin
edman
degrad
intact
protein
ntermin
sequenc
peptid
fragment
obtain
endopeptidas
cyanogen
bromid
treatment
wildtyp
protein
alga
contain
uncommon
amino
acid
da
posit
replac
alanin
ala
recombin
protein
prepar
without
affect
antihiv
activ
grft
homolog
protein
previous
report
shown
antihiv
activ
cell
tropic
macrophagetrop
virus
capabl
inhibit
cellcel
fusion
chronic
infect
uninfect
cell
efficaci
antivir
agent
envelop
virus
also
shown
see
section
largescal
express
system
essenti
develop
grft
afford
drug
end
grft
express
recombinantli
differ
organ
tabl
first
express
recombinantli
escherichia
coli
e
coli
polyhistidin
tag
nterminu
facilit
purif
metal
affin
chromatographi
express
grft
nicotiana
benthamiana
use
infecti
tobacco
mosaic
viru
tmv
base
vector
yield
gram
amount
protein
express
rice
seed
stabl
transform
plant
also
report
purif
grft
also
optim
includ
use
ceram
filtrat
follow
twostag
chromatographi
combin
heat
magnesium
chlorid
bentonit
follow
singl
chromatograph
step
importantli
grft
express
purif
proven
robust
essenti
featur
make
drug
avail
clinic
test
griffithsin
exist
stabl
homodim
subunit
contain
amino
acid
figur
cystein
sequenc
homolog
protein
structur
grft
absenc
ligand
well
presenc
differ
monosaccharid
disaccharid
solv
xray
crystallographi
grft
fold
domainswap
dimer
figur
subunit
present
nearli
perfect
intern
threefold
symmetri
structur
compos
three
repeat
antiparallel
fourstrand
superfici
resembl
motif
found
lectin
jacalin
famili
two
amino
acid
swap
one
monom
form
three
fourstrand
sheet
subunit
homodim
griffithsin
capabl
bind
three
monosaccharid
bind
site
locat
equilater
triangl
site
separ
approxim
figur
crystal
structur
monosaccharid
mannos
glucos
nacetylglycosamin
disaccharid
maltos
report
interact
oligosaccharid
shown
grft
preferenti
interact
termin
sugar
crystal
mannos
shown
bind
site
almost
ident
one
contain
aspart
acid
asp
residu
make
extens
contact
sugar
includ
make
hydrogen
bond
interact
mannos
figur
mutat
residu
ala
affect
fold
protein
weaken
bind
mannos
column
attempt
crystal
grft
oligosaccharid
mostli
unsuccess
extens
precipit
protein
presenc
oligosaccharid
problem
solv
moulaei
et
al
abl
creat
monomer
version
grft
mgrft
insert
short
linker
glyser
separ
undergo
intermolecular
domain
swap
second
mutat
leucin
posit
serin
introduc
minim
hydrophob
patch
opposit
swap
region
complex
mgrft
bound
synthet
nonamannosid
contain
nine
mannos
residu
present
fulllength
mannonanosedi
nacetyldglucosamin
lack
core
structur
found
two
three
arm
nonamannosid
bound
two
three
mannosebind
site
figur
particular
termin
mannos
unit
arm
bound
site
defin
ref
respect
third
mannosebind
site
site
occupi
arm
anoth
nonamannosid
like
transient
interact
interact
inconsist
model
propos
et
al
propos
three
arm
man
glcnac
could
interact
grft
onetoon
stoichiometri
addit
crystal
structur
nmr
assign
backbon
atom
grft
absenc
ligand
presenc
mannos
report
crystal
structur
grft
mannosid
complex
suggest
import
asp
residu
present
three
mannos
bind
site
singl
mutat
one
asp
residu
ala
slightli
weaken
affin
bind
envelop
glycoprotein
howev
singl
mutat
significantli
decreas
potenc
inhibit
singl
round
hiv
infect
cytopath
assay
well
celltocel
transmiss
assay
cocultiv
assay
studi
import
three
bind
site
monom
xue
et
al
design
seri
mutant
two
monom
connect
amino
acid
linker
express
form
oblig
dimer
compar
construct
six
bind
site
three
monom
mutant
three
bind
site
one
subunit
mutat
abolish
bind
mannos
onearm
oblig
dimer
anoth
mutant
six
mannos
bind
site
mutat
bind
studi
show
oblig
dimer
well
construct
contain
mannos
bind
site
one
subunit
bound
compar
affin
wherea
mutant
lack
mannos
bind
site
bind
contrast
neutral
assay
show
antihiv
activ
onearm
oblig
dimer
reduc
sever
order
magnitud
compar
wildtyp
oblig
dimer
isotherm
titrat
calorimetri
itc
show
bind
monoand
disaccharid
exotherm
entrop
favor
micromolar
k
valu
enthalpi
among
differ
saccharid
indic
favor
electrostat
contact
larg
chang
entropi
reason
larg
displac
water
molecul
bind
site
interestingli
nonamannosid
bind
larg
enthalp
driven
entrop
unfavor
indic
format
favor
contact
sugar
protein
unfavor
entropi
bind
indic
multival
interact
grft
nonamannosid
diminish
degre
freedom
glycan
protein
use
structur
carbohydr
bind
arrang
grft
micewicz
et
al
construct
peptid
contain
three
coval
link
beta
sheet
display
threefold
symmetri
inhibit
laboratori
strain
hiv
bound
viral
glycoprotein
though
antivir
potenc
reduc
mani
hundredfold
compar
grft
nevertheless
exhibit
submicromolar
half
maxim
inhibitori
concentr
ic
singleround
hiv
infect
assay
enhanc
abil
grft
inhibit
hiv
infect
kagiampki
et
al
creat
coval
link
fusion
protein
compos
grft
known
hiv
entri
inhibitor
acid
peptid
contain
sequenc
ctermin
region
hiv
transmembran
protein
block
hiv
fusion
bind
ntermin
helic
prevent
format
sixhelix
bundl
lead
membran
fusion
fusion
construct
demonstr
improv
potenc
compar
grft
alon
cc
chemokin
receptor
type
tropic
cxc
chemokin
receptor
type
tropic
cellcel
fusion
assay
singleround
infect
assay
follow
work
monomer
grft
moulaei
cowork
creat
sever
grft
tandem
tandem
protein
construct
link
grft
monom
one
anoth
coval
linkag
form
insert
glythrgli
linker
tandem
analyz
electron
microscopi
show
doubl
tripl
repeat
exist
linear
arrang
tandem
contain
four
mgrft
repeat
form
globular
structur
hiv
neutral
assay
improv
potenc
observ
doubl
tripl
tandem
potenc
plateau
increas
potenc
observ
mgrft
construct
grft
unusu
stabl
protein
withstand
extract
procedur
use
natur
product
isol
purif
may
includ
exposur
organ
solvent
repeat
lyophil
addit
physicochem
stabil
resist
proteas
degrad
establish
studi
examin
stabil
antimicrobi
peptid
author
show
grft
resist
digest
eight
nine
differ
proteas
degrad
metalloproteas
elastas
addit
grft
affect
bacteri
degrad
condit
import
intermolecular
crosslink
grft
suggest
sever
public
evid
obtain
protein
perspect
well
glycan
perspect
shown
monomer
grft
bind
compar
affin
yet
ic
neutral
sever
order
magnitud
weaker
wildtyp
grft
crystal
structur
synthet
nonamannosid
obtain
monomer
grft
construct
mode
bind
seen
crystal
disagr
model
propos
three
termin
mannos
unit
man
interact
mannosebind
site
grft
inabl
man
engag
three
bind
site
grft
support
studi
show
glycopeptid
mimic
man
requir
distanc
greater
separ
arm
natur
man
glcnac
order
engag
three
bind
site
simultan
recent
cryoelectron
microscopi
surfac
plasmon
reson
studi
viral
particl
treat
grft
grft
mutant
demonstr
uniqu
combin
multival
strict
recognit
man
homodimer
structur
grft
led
bridg
viral
particl
aggreg
abil
monomer
grft
tandem
link
togeth
glythrgli
amino
acid
linker
show
two
individu
monomer
unit
need
recov
improv
potenc
wildtyp
grft
three
unit
mgrft
improv
neutral
potenti
even
howev
improv
potenc
observ
tandem
contain
greater
number
mgrft
domain
interestingli
dynam
light
scatter
show
wildtyp
grft
caus
viru
aggreg
howev
monomer
grft
well
mgrft
tandem
caus
viru
aggreg
addit
cryoelectron
microscopi
show
virus
expos
wildtyp
grft
protein
aggreg
surfac
immunostain
perform
grft
shown
antivir
activ
number
envelop
virus
describ
section
though
predict
number
glycan
vari
consider
among
virus
inhibit
grft
figur
antivir
activ
nonetheless
attribut
carbohydratemedi
bind
respect
viral
envelop
glycoprotein
list
effect
concentr
inhibit
viru
infect
ec
present
tabl
hiv
studi
target
nativ
grft
cemss
recombin
grft
cemss
nativ
grft
pbmc
nativ
grft
macrophag
nativ
grft
macrophag
recombin
grft
pmbc
recombin
grft
recombin
grft
recombin
grft
siv
recombin
synaps
form
high
amount
present
surfac
hivinfect
cell
bind
receptor
uninfect
cell
interact
trigger
conform
chang
need
coreceptor
bind
follow
mediat
membran
fusion
shown
grft
capabl
inhibit
vitro
infect
clade
b
c
virus
clade
least
sensit
grft
addit
shown
sensit
inhibit
highli
depend
number
glycan
surfac
shown
singlecycl
pseudotyp
tzmbl
cell
neutral
assay
gener
sensit
neutral
pmbc
assay
grft
shown
inhibit
fusion
infect
cell
noninfect
cell
grft
also
capabl
prevent
infect
cervic
explant
celltocel
transmiss
migratori
cell
explant
thu
grft
abil
block
hiv
infect
numer
assay
platform
interestingli
even
though
monomer
grft
compar
affin
toward
nonamannosid
show
decreas
abil
bind
even
dramat
decreas
inhibit
hiv
infect
cemss
cell
indic
crosslink
multipl
highmannos
sugar
respons
high
potenc
lectin
grft
hiv
transmiss
believ
mediat
predominantli
transmittedfound
tf
virus
virus
show
differenti
glycosyl
compar
chronic
virus
effect
grft
tf
virus
measur
found
great
variabl
ic
valu
grft
tf
virus
interestingli
even
though
correl
number
possibl
nlink
glycosyl
site
sensit
grft
tf
virus
seem
correl
number
locat
highmannos
glycan
site
resist
grft
lastli
shown
grft
block
replic
cell
cultur
ec
valu
subnanomolar
rang
bind
envelop
glycoprotein
grft
shown
bind
hiv
envelop
glycoprotein
therebi
block
bind
well
bind
antihiv
antibodi
includ
conformationspecif
monoclon
antibodi
mab
bind
epitop
carbohydratespecif
mab
interestingli
bind
lectin
cyanovirinn
cvn
shown
inhibit
subsequ
bind
grft
contrast
grft
bind
block
subsequ
bind
cvn
could
suggest
grft
smaller
recognit
epitop
lower
stoichiometri
bind
compar
cvn
howev
itc
experi
show
total
approxim
grft
unit
capabl
bind
singl
glycoprotein
regard
time
inhibit
grft
shown
initi
antivir
activ
immedi
upon
contact
repres
advantag
compar
antiretrovir
agent
nucleosid
phosphon
r
adenin
pmpa
must
administ
prodrug
ester
shown
grft
compet
glycanspecif
antibodi
mab
bind
high
mannos
patch
enhanc
bind
antibodi
specif
bind
site
includ
mab
chimer
molecul
mab
broadli
neutral
antibodi
wherea
mab
nonneutr
fusion
protein
use
surrog
variabl
region
molecul
replac
solubl
region
receptor
delet
glycan
posit
decreas
grftmediat
increas
bind
data
support
observ
grft
mab
act
synergist
delet
glycan
asparagin
asn
prevent
synergist
effect
contrast
enhanc
bind
bind
site
shown
grft
inhibit
bind
coreceptor
bind
sitespecif
mab
without
directli
occlud
bind
site
alexandr
et
al
show
bind
grft
glycan
like
interfer
conform
chang
need
coreceptor
bind
anoth
studi
show
presenc
grft
partial
inhibit
bind
site
mab
epitop
mab
presenc
absenc
solubl
suggest
presenc
grft
might
compromis
exposur
bind
site
investig
effect
grft
expos
xue
et
al
show
six
mannosebind
site
need
expos
site
mutant
lack
mannosebind
site
one
domain
show
exposur
show
bind
grft
induc
shed
effect
mark
clade
b
strain
clade
c
dendrit
cell
antigenpres
cell
respons
captur
degrad
pathogen
enter
mucos
environ
dc
also
play
import
role
viral
transmiss
dc
cell
present
dcsign
dendrit
cell
intercellular
adhes
molecul
grab
nonintegrin
receptor
surfac
dc
migrat
lymph
node
dcsign
receptor
mediat
transmiss
uninfect
cell
believ
interact
dendrit
cell
dcsign
receptor
mediat
transfer
lymph
node
infect
cell
dcsign
mediat
transfer
hiv
target
cell
involv
bind
viru
dcsign
receptor
process
occur
interact
highmannos
glycan
surfac
envelop
glycoprotein
dcsign
follow
transfer
target
cell
infect
grft
shown
inhibit
process
addit
singlesit
mutat
mannosebind
site
grft
shown
significantli
diminish
dcsign
associ
celltocel
transmiss
competit
assay
shown
grft
inhibit
bind
dcsign
grft
cytotox
dc
trigger
dc
apoptosi
matur
sever
excel
studi
investig
mechan
grft
resist
hiv
publish
surprisingli
one
strategi
use
hiv
lectin
well
glycantarget
mab
involv
delet
glycosyl
site
figur
alexandr
et
al
perform
extens
analysi
compar
ic
valu
observ
grft
numer
subtyp
b
strain
glycosyl
naturallyoccur
virus
result
show
virus
miss
glycosyl
asn
site
less
sensit
grft
howev
absenc
one
glycosyl
site
affect
sensit
addit
number
miss
glycan
correl
sensit
grft
locat
glycosyl
site
clear
effect
efficaci
huang
et
al
hand
investig
role
glycan
asn
background
subtyp
c
hiv
strain
mutant
singl
delet
either
two
glycosyl
site
show
decreas
suscept
grft
less
sensit
doubl
mutant
show
even
pronounc
decreas
grft
sensit
differ
studi
strain
lack
glycan
posit
show
lower
sensit
grft
strain
miss
glycan
significantli
reduc
sensit
separ
studi
morri
moor
laboratori
examin
mechan
resist
subtyp
c
strain
lectin
includ
grft
found
virus
cultur
presenc
increas
concentr
grft
evolv
delet
sever
glycan
includ
posit
insert
delet
amino
acid
near
glycosyl
site
loop
would
expect
alter
glycosyl
also
observ
importantli
natur
resist
evolv
studi
other
suggest
multipl
glycosyl
site
mutat
requir
viru
becom
resist
grft
level
resist
fold
compar
wild
type
anoth
studi
examin
effect
differ
lectin
oscillatoria
agardhii
agglutinin
oaa
grftresist
iiib
strain
gener
result
delet
glycan
posit
multipl
mutat
decreas
grft
suscept
fold
though
studi
examin
correspond
effect
glycosyl
site
delet
viral
fit
limit
studi
report
decreas
infect
recombin
strain
number
laboratori
studi
synergist
activ
grft
protein
includ
antibodi
lectin
well
commonli
use
antivir
surfac
envelop
glycoprotein
transmembran
protein
shown
yellow
gray
surfac
respect
receptor
coreceptor
bind
site
color
blue
purpl
respect
glycan
found
delet
resist
studi
color
red
glycan
glycan
shown
delet
grftresist
strain
present
structur
includ
glycan
model
render
pymol
model
construct
c
soto
pdb
access
number
render
pymol
separ
studi
morri
moor
laboratori
examin
mechan
resist
subtyp
c
strain
lectin
includ
grft
found
virus
cultur
presenc
increas
concentr
grft
evolv
delet
sever
glycan
includ
posit
insert
delet
amino
acid
near
glycosyl
site
loop
would
expect
alter
glycosyl
also
observ
importantli
natur
resist
evolv
studi
other
suggest
multipl
glycosyl
site
mutat
requir
viru
becom
resist
grft
level
resist
fold
compar
wild
type
anoth
studi
examin
effect
differ
lectin
oscillatoria
agardhii
agglutinin
oaa
grftresist
iiib
strain
gener
result
delet
glycan
posit
multipl
mutat
decreas
grft
suscept
fold
though
studi
examin
correspond
effect
glycosyl
site
delet
viral
fit
limit
studi
report
decreas
infect
recombin
strain
number
laboratori
studi
synergist
activ
grft
protein
includ
antibodi
lectin
well
commonli
use
antivir
monoclon
antibodi
use
sever
studi
recogn
carbohydratedepend
epitop
compris
cluster
high
mannos
glycan
includ
glycan
asn
residu
site
suggest
target
grft
basi
resist
profil
competit
enzymelink
immunosorb
assay
elisa
captur
grfttreat
viru
immobil
show
protein
competit
one
anoth
howev
combin
grft
shown
synergist
strain
bal
pbmc
cultur
studi
grft
synerg
bind
site
mab
plasma
hivposit
individu
antibodi
mab
grft
also
found
synergist
solubl
version
receptor
owe
potenc
gener
potenti
topic
microbicid
numer
studi
look
effect
synergi
grft
lectin
includ
mannanbind
lectin
mvn
banana
lectin
banlec
hippeastrum
hybrid
amarylli
lectin
hha
galanthu
nivali
lectin
gna
viru
infect
assay
synergi
pronounc
lectin
resist
strain
banlec
also
shown
addit
effect
grft
celltocel
transmiss
assay
interestingli
grft
show
addit
effect
oaa
wherea
show
antagon
lectin
hybrid
oaahomolog
protein
opa
synergi
studi
employ
grft
hivneutr
antibodi
type
assay
may
play
role
observ
outcom
shown
grft
synerg
known
drug
includ
nucleotid
revers
transcriptas
inhibitor
tenofovir
hiv
coreceptor
antagonist
maraviroc
fusion
inhibitor
enfuvitrid
specif
antagonist
use
differ
clade
viru
infect
assay
well
cellcel
transmiss
assay
drug
individu
combin
antihiv
drug
shown
promis
candid
microbicid
develop
combin
grft
molecul
believ
great
potenti
develop
microbicid
tenofovir
shown
synergist
effect
grft
grft
shown
inhibit
infect
hcv
hepatocyt
vitro
well
celltocel
transmiss
import
clinic
relev
follow
liver
transplant
hcvinfect
patient
reinfect
new
liver
graft
commonli
occur
coimmunoprecipit
studi
show
grft
interact
envelop
glycoprotein
prevent
subsequ
interact
one
hcv
receptor
contrast
elisa
experi
show
grft
inhibit
bind
infect
significantli
inhibit
nonamannosid
indic
like
case
hiv
grft
interact
highmannos
glycan
surfac
hcv
grft
treatment
chimer
mice
liver
engraft
function
primari
human
hepatocyt
show
significantli
lower
viru
titer
compar
treatment
grft
mutant
bind
site
mutat
prevent
bind
glycan
even
though
mutat
occur
upon
exposur
hcv
grft
attempt
gener
resist
grft
fail
detect
specif
envelop
mutat
confer
resist
lectin
coronavirida
envelop
positivestrand
virus
caus
agent
sever
acut
respiratori
syndrom
sar
wellknown
strain
outbreak
includ
sarscov
outbreak
merscov
outbreak
grft
shown
inhibit
corona
viru
replic
cytopath
induc
sarscov
well
coronavirida
virus
particular
grft
inhibit
differ
strain
sarscov
infect
vero
cell
ec
low
nanomolar
rang
minim
toxic
control
cell
grft
bind
glycan
surfac
sarscov
spike
glycoprotein
total
three
molecul
grft
capabl
bind
dose
depend
manner
high
affin
lower
number
compar
probabl
due
lower
number
highmannos
glycan
surfac
interestingli
interact
inhibit
bind
sarscov
glycoprotein
host
cell
human
receptor
angiotensin
convert
enzym
studi
mouseadapt
sarscov
show
mice
receiv
daili
dose
intranas
administ
grft
surviv
rate
loss
weight
improv
lung
histopatholog
score
reduct
lung
tissu
viru
titer
compar
control
group
experienc
weight
loss
surviv
rate
studi
might
prove
grft
good
candid
molecul
treat
respiratori
infect
japanes
enceph
viru
mosquitoborn
flaviviru
similar
dengu
yellow
fever
zika
envelop
glycoprotein
jev
contain
two
potenti
glycosyl
site
import
viru
infect
shown
grft
inhibit
infect
babi
hamster
kidney
bhk
cell
ic
nanomolar
rang
inhibit
due
interact
grft
glycosyl
viral
protein
envelop
e
premembran
prm
addit
mice
challeng
lethal
dose
jev
show
reduc
viru
titer
mous
brain
surviv
rate
compar
surviv
rate
control
group
vitro
studi
grft
show
weaktomoder
activ
block
entri
yet
capabl
inhibit
celltocel
spread
ic
nanomolar
rang
vivo
studi
use
murin
model
gel
contain
grft
significantli
protect
mice
challeng
compar
control
group
shown
prevent
viral
spread
postchalleng
continu
protect
viru
introduc
semin
plasma
though
grft
treatment
led
small
declin
epitheli
barrier
integr
polar
cell
cultur
increas
hiv
migrat
observ
establish
safeti
prevent
vitro
bind
immunoprecipit
studi
suggest
grft
block
infect
interact
one
four
glycoprotein
involv
entri
name
glycoprotein
vitro
experi
shown
grft
antihpv
activ
rang
high
nanomolar
low
micromolar
rang
hpv
nonenvelop
viru
interestingli
found
grft
block
initi
attach
viru
cell
instead
act
late
step
hpv
entri
process
data
suggest
grft
interact
hpv
secondari
receptor
integrin
decreas
avail
cell
surfac
grft
decreas
hpv
pseudoviru
psv
vagin
infect
murin
model
studi
investig
effect
three
lectin
delta
gamma
retrovirus
includ
human
cell
leukemia
viru
grft
effect
trichomoniasi
sexual
transmit
parasit
diseas
caus
trichomona
vaginali
develop
microbicid
agent
hiv
benefit
also
prevent
trichomona
grft
bind
surfac
trichomona
tritrichomona
caus
flagel
trichomonad
undergo
selfaggreg
precipit
interact
like
due
bind
grft
unprocess
glycan
surfac
parasit
topic
applic
grft
infect
tritichomona
mice
reduc
recoveri
parasit
mice
elimin
cytotox
profil
grft
studi
extens
grft
well
known
prevent
infect
number
divers
virus
sign
cellular
toxic
varieti
cell
even
concentr
high
nm
use
antivir
therapeut
mode
grft
administr
may
determin
mechan
viru
infect
new
host
exampl
case
hiv
promis
applic
topic
microbicid
microbicid
carri
substanti
risk
system
side
effect
unlik
absorb
effici
altern
respiratori
infect
via
sarscov
grft
could
administ
intranas
spray
intraven
case
hcv
studi
shown
grft
stabl
maintain
similar
antihiv
activ
incub
long
period
time
varieti
environ
includ
acid
ph
cervicalvagin
lavag
fluid
pigtail
macaqu
grft
bind
outermost
layer
squamou
epithelium
human
cervic
epithelium
howev
loss
cell
viabil
endocerv
ectocerv
cell
line
observ
even
dose
mgml
grft
addit
grft
induc
cell
prolifer
cervicovagin
cell
line
contrast
lectin
show
high
cytotox
signific
mitogen
activ
treatment
human
cervic
explant
well
cultur
human
endocerv
ectocerv
vagin
cell
line
grft
intravagin
grft
treatment
rabbit
shown
signific
perturb
level
cytokin
chemokin
rna
microarray
analysi
cultur
ectocerv
cell
line
show
grft
treatment
minim
alter
gene
express
profil
vivo
rabbit
vagin
irrit
rvi
assay
show
good
safeti
profil
grft
inflammatori
respons
damag
epithelia
rvi
test
requir
food
drug
administr
fda
proceed
clinic
test
hiv
infect
pbmc
often
use
evalu
hiv
infect
grft
bind
surfac
pmbc
prevent
viral
replic
even
wash
cell
howev
exposur
human
pbmc
three
day
show
mitogen
activ
stimul
lymphocyt
prolifer
grft
stimul
express
pmbc
activ
marker
immun
activ
name
marker
cell
activ
minim
effect
cytokin
chemokin
releas
pmbc
grft
also
propos
treat
respiratori
infect
sar
case
protein
would
administ
intranas
preliminari
studi
grft
administ
intranas
sarscov
infect
mice
show
level
cytokin
decreas
compar
infect
sarscov
alon
perivascular
infiltr
observ
grfttreat
mice
howev
analysi
perform
subcutan
inject
test
show
potenti
grft
treat
hcv
subcutan
inject
grft
immunodefici
transgen
mice
indic
lectin
remain
bioavail
even
day
mild
transient
alter
health
paramet
bodi
weight
morbid
score
howev
prolong
dose
deleteri
effect
overal
health
mice
author
studi
suggest
could
consequ
inher
fragil
mous
model
toxic
implant
human
hepatocyt
treatment
hcvchalleng
transgen
mice
show
log
reduct
hcv
viral
titer
grfttreat
mice
anoth
hcv
anim
model
subcutan
inject
chimer
mice
harbor
human
hepatocyt
liver
result
two
six
anim
death
similar
previou
studi
author
suggest
like
due
fragil
natur
mice
use
model
rather
lectininduc
toxic
lastli
intraperiton
administr
grft
mice
lethal
dose
jev
result
surviv
wherea
none
mice
control
group
surviv
pharmacokinet
properti
grft
test
two
rodent
model
subcutan
inject
high
amount
grft
mgkg
show
grft
persist
plasma
least
two
week
sera
test
hiv
infect
assay
demonstr
grft
sera
retain
antivir
activ
time
anim
surviv
high
dose
grft
treatment
accumul
spleen
kidney
liver
observ
although
minim
sign
toxic
seen
juvenil
anim
show
weight
loss
compar
control
anim
importantli
author
unabl
detect
antigrft
antibodi
sera
even
high
dose
anim
anoth
studi
assess
immunogen
gag
presenc
absenc
grft
immun
mice
complex
enhanc
respons
compar
mice
immun
alon
immun
nonglycosyl
gaggrft
complex
effect
level
antigag
antibodi
compar
immun
gag
alon
interestingli
increas
antigrft
immun
respons
observ
mice
immun
gaggrft
complex
lead
author
conclud
immun
grftbound
may
improv
humor
immun
respons
grft
belong
group
lectin
capabl
inhibit
hiv
infect
well
infect
envelop
virus
grft
bind
termin
mannos
unit
present
high
mannos
oligosaccharid
present
surfac
variou
viral
envelop
glycoprotein
structur
studi
xray
crystallographi
nmr
shown
uniqu
structur
distribut
mannos
bind
site
engend
grft
unpreced
abil
block
hiv
much
lower
concentr
antihiv
drug
even
though
grft
three
mannos
bind
site
subunit
shown
two
simultan
engag
man
oligosaccharid
leav
third
bind
site
avail
bind
second
man
molecul
precis
distribut
carbohydr
bind
site
togeth
multival
charact
grft
aris
homo
dimer
structur
lead
format
complex
crosslink
network
like
one
determin
factor
picomolar
activ
given
primari
bind
site
grft
compris
carbohydr
present
surfac
reason
evalu
activ
envelop
virus
virus
shown
sensit
grft
inhibit
contain
moderateto
heavilyglycosyl
envelop
high
densiti
highmannos
oligosaccharid
present
mani
therapeut
potenti
grft
virus
depend
mode
entri
viru
close
grow
bodi
literatur
establish
remark
potenc
broadspectrum
antivir
activ
safeti
profil
grft
support
develop
microbicid
especi
diseas
prevent
measur
unavail
